Pressure Dependent Tracheal Obstruction in Copd Patients (PDTO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01679808 |
Recruitment Status :
Completed
First Posted : September 6, 2012
Last Update Posted : September 6, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background. Do pressure dependent tracheal obstructions (PDTO) often seen during bronchoscopy in COPD patients affect pulmonary function tests and breathing symptoms? Method. Model study. A garden hose was compressed from one side to simulate the posterior wall of the trachea bulging into the lumen. For two obstruction lengths - 3 cm and 12 cm, the hose was increasingly compressed in eight steps. Resistance was measured at each step for airflows 1 l/s through 9 l/s, and digital photos of the luminal area were taken which were used by a computer to estimate the cross sectional area reduction and the corresponding distance between the bulging (posterior)and the opposite (anterior) wall (AP-distance).
Patient study. 104 stable COPD patients studied by pulmonary function tests and bronchoscopy. The tracheal obstruction was observed during forced expiration and cough, and the cross sectional area reduction was estimated using the results from the model study.
Condition or disease |
---|
Tracheobronchomalacia |
Study Type : | Observational |
Actual Enrollment : | 104 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Pressure Dependent Tracheal Obstruction in Copd Patients |
Study Start Date : | August 2004 |
Actual Primary Completion Date : | August 2006 |
Actual Study Completion Date : | August 2011 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- copd
Exclusion Criteria:
- clinical evidence of malignant disease
- not able to be subjected to bronchoscopy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01679808
Norway | |
Glittreklinikken | |
Hakadal, Akershus, Norway, 1485 |
Principal Investigator: | Ivar Ellingsen, Dr med | LHL Helse |
Responsible Party: | LHL Helse |
ClinicalTrials.gov Identifier: | NCT01679808 |
Other Study ID Numbers: |
GK-18 s-04058c ( Registry Identifier: The National Committees for Research Ethics in Norway ) |
First Posted: | September 6, 2012 Key Record Dates |
Last Update Posted: | September 6, 2012 |
Last Verified: | September 2012 |
copd airway obstruction Tracheobronchomalacia |
Tracheobronchomalacia Cartilage Diseases Musculoskeletal Diseases Bronchial Diseases Respiratory Tract Diseases |
Tracheal Diseases Musculoskeletal Abnormalities Congenital Abnormalities Connective Tissue Diseases |